Filter posts

Antibiotic Development Incentives May Be Tricky to Implement

A recently proposed broad suite of antibiotic development incentives has received strong support from industry …

Janet Napolitano and Jim Greenwood Talk Innovation, Homeland Security, and Politics at #BIO2016 Fir...

Janet Napolitano, President of the University of California, emphasized the need for research at every …

Achieving Healthcare Sustainability: Can we Move from “Value” to “Predictability”?

Drug costs are one of largest healthcare concerns across the American political spectrum. But drug …

Shifting CAR-Ts Into a Higher Gear

After a three-year run-up of mounting excitement over CAR-T therapies comes crunch time. Over the …

Virtual Reality Meets the Operating Room: Digital Health Summer Summit Audience Experiences a Live S...

If you thought Virtual Reality was just something to be used at the movies or …

The Value of Lifesaving Medicines: How Best To Define and Communicate The Innovations In Biopharmace...

One of BIO’s central goals is to promote the value of innovation in lifesaving medicines …

The U.S. Department of Defense returns to the BIO Convention in 2016

The Joint Project Manager for Medical Countermeasure Systems (JPM-MCS), a program within the U.S. Department …

Imagine How Much Faster We Could Address Emerging Infections Like Zika and Dengue If We Worked Even ...

In just a few months, Brazil will host the 2016 Olympics, the most competitive global …

BIO Releases Largest Study Ever on Clinical Development Success Rates

On Wednesday, BIO released the largest ever study of clinical development success rates. The study, conducted in …

A Closer Look at AHIP’s Claims

This morning, in a letter to the editor of the New York Times, Marilyn Tavenner, …